Why Medicare Isn't a Game Changer for Weight-Loss Drugmakers — Heard on the Street — WSJ
By David WainerMedicare began covering weight-loss drugs for seniors this week. For patients long shut out from the GLP-1 boom, the opening is a real milestone. For Wall Street, it isn't the immediate windfall the headlines suggest.Drugs such as Wegovy and Zepbound have rocketed into the national s…